Sort
50,496 grants matching “lung cancer”
Project 2: Susceptibility of Lung Cancer Cells to SARS- CoV-2 Infection and Antibody-Mediated Neutralization
$395,967Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U54 · FY2022 · CA
A Cancer Rainbow Mouse for Simultaneous Assessment of Multiple Oncogenes
$395,912Marc G. Caron · Duke University · R33 · FY2016 · CA
Identification of Small Molecule Inhibitors of QSOX1
$395,880Sergei Svarovsky · Sapphire Biotech, Inc. · R43 · FY2020 · CA
Video Intervention to Address Pre-Test Patient Education for Tumor Genomic Testing
$395,878Daniel G. Stover · Ohio State University · R21 · FY2021 · CA
Project 1: Biomarkers Of Exposure Versus Effect: Improving The Scientific Basis F
$395,818James A Swenberg · Univ Of North Carolina Chapel Hill · P42 · FY2015 · ES
Raman Probe for Bronchial Premalignant Lesions
$395,798Stephen Frederick Fulghum · Newton Laboratories · R44 · FY2007 · HL
Crosstalk of LKB1 and KEAP1 mutations in driving growth of lung adenocarcinoma
$395,755Shyam Biswal · Johns Hopkins University · R01 · FY2018 · CA
Investigating Abbapolin PLK1 Polo Box Domain inhibitors as potential therapeutics for colorectal cancers
$395,724Campbell McInnes · Ppi Pharmaceuticals, Llc · R41 · FY2025 · CA
MicroRNA Therapy for Lymph Node Metastatic Breast Cancer
$395,711Zdravka O. Medarova · Massachusetts General Hospital · R01 · FY2015 · CA
MicroRNA Therapy for Lymph Node Metastatic Breast Cancer
$395,711Zdravka O. Medarova · Massachusetts General Hospital · R01 · FY2016 · CA
Periostin Regulation of Lung Fibrosis
$395,698Bethany B. Moore · University Of Michigan At Ann Arbor · R01 · FY2013 · HL
Clinical Hematology Research Career Development Program (K12)
$395,696Ellis J Neufeld · Boston Children'S Hospital · K12 · FY2009 · HL
Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis
$395,689Ann Marie Pendergast · Duke University · R01 · FY2024 · CA
DDR2 kinase inhibition in squamous cell lung carcinomas
$395,684Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2016 · CA
DDR2 kinase inhibition in squamous cell lung carcinomas
$395,684Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2015 · CA
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells
$395,654Joan Siefert Brugge · Harvard Medical School · R01 · FY2017 · CA
Kentucky Cancer Prevention and Control Training Program (R25T)
$395,643Mark B. Dignan · University Of Kentucky · R25 · FY2008 · CA
Lung Navigation System for Localizing and Resecting Nodules
$395,640Jayender Jagadeesan · Brigham And Women'S Hospital · R01 · FY2018 · EB
Development of a tumor-retentive immunostimulant as adjunct therapy for solid tumor cancers
$395,595Marcus Laird Forrest · Kinimmune, Inc. · R41 · FY2022 · CA
Contribution of development and age to breast cancer etiology
$395,569Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2020 · CA
A DNA Methylation Test for Guiding Lung Cancer Screening
$395,569Robert A Philibert · Bd Holding, Inc. · R43 · FY2021 · CA
Unlocking transcript diversity via differential analyses of splice graphs
$395,553Jan F Prins · Univ Of North Carolina Chapel Hill · R01 · FY2013 · HG
MOLECULAR GENETICS OF MOUSE LUNG TUMORS
$395,548Ohio State University · R01 · FY2000 · CA
Research and Methods Core
$395,524Katharine A. Rendle · University Of Pennsylvania · P50 · FY2023 · CA
Exploring Statin Pleiotropic Effects within a Very Large EHR Cohort
$395,483Wei-Qi Wei · Vanderbilt University Medical Center · R01 · FY2020 · HL